Quit Genius has been validated in a randomized-controlled trial and 6 peer-reviewed studies and counting.
Our single-blinded randomized controlled trial compared Quit Genius against Usual Care in 530 participants. Carbon Monoxide verified outcomes demonstrated a 52% quit rate in the Quit Genius versus 32% in the Usual Care arm at 28 days post quit date.
READ THE PAPERPreliminary Outcomes of a Digital Therapeutic Intervention for Smoking Cessation in Adult Smokers: Randomized Controlled Trial
Webb et al. / JMIR Mental Health
View paperUsing Health and Well-Being Apps for Behavior Change: A Systematic Search and Rating of Apps
McKay et al. / JMIR Mhealth Uhealth
View paperUse of Gamification Strategies and Tactics in Mobile Applications for Smoking Cessation: A Review of the UK Mobile App Market
Rajani et al. / BMJ Open
View paperEvaluating Mobile Phone Applications for Health Behaviour Change: A Systematic Review
McKay et al. / J Telemed Telecare
View paperEffective Behavioral Changes through a Digital mHealth App
Lin et al. / JMIR Mhealth Uhealth
View paperEvaluation of Two Mobile Health Apps in the Context of Smoking Cessation
Tudor-Sfetea et al. / JMIR Mhealth
View paperGame On? Smoking Cessation Through the Gamification of mHealth: A Longitudinal Qualitative Study
El-Hilly et al. / JMIR Serious Games
View paperQuit Genius breaks the shell with an evidence-based program designed to engage and set each member up for a successful quit attempt.
The purpose of this randomised clinical trial is to compare the effectiveness of the Quit Genius app to “very brief advice” on quitting smoking. As well as smoking abstinence, the study will also look at the quality of life, self-efficacy and wellbeing of Quit Genius users.
Academic collaborators:
In collaboration with researchers at Imperial College London the purpose of this study is to investigate the impact of Quit Genius on the self-efficacy and motivation of smokers wanting to quit. Cessation outcomes and app-engagement will also be assessed.
Academic collaborators: